GLOW 70
GLOW, a 70 mg skin-and-repair blend (GHK-Cu 50 + BPC-157 10 + TB-500 10) in one click pen. Each click delivers 233 µg from a 3 mL · 300-click pen.
Featured in these stacks: Advanced Summer Stack.
how many clicks
for your dose?
This GLOW 70 pen holds 70 mg across 300 clicks, so each click delivers 233 µg. Tap a dose or turn the dial; we'll count the clicks. For research reference only.
why researchers chose this pen
chose it for the click dosing, no syringes, no unit maths.
verified purity, checked against the public CoA before first use.
precise clicks in every 3 mL pen, the whole protocol in one barrel.
re-order or refer a colleague within three months.
about the
GLOW 70 pen
GLOW pairs GHK-Cu with BPC-157 and TB-500 in a single 70 mg blend pen (50 + 10 + 10), for skin and repair research.
Certificate of analysiswhy a pen beats
a vial & syringe
Traditional research peptides arrive as lyophilised powder that must be reconstituted, drawn into insulin syringes, and converted from milligrams to units by hand, every step a chance for a dosing error.
A multi-dose pen removes the whole failure chain. The peptide arrives already dissolved and calibrated. Attach a fresh needle, turn the dial until you count your clicks, and you're done, the same audible-click mechanism trusted in insulin and GLP-1 pens worldwide.
Pens travel and store better, too: no open vials, no bent needles, no septum contamination after repeated draws. One sealed barrel, ten sterile needles, one dosing card.
how to buy
peptides safely
The peptide market has a purity problem: independent surveys routinely find underdosed, mislabelled or contaminated product sold online. The only reliable defence is third-party verification you can check yourself, not a supplier's own claims.
Before buying any peptide pen, ask three questions. Is every batch tested by an independent lab? Is the certificate of analysis available, so you can check your exact lot before first use? And does it ship cold-chain, insulated and gel-packed, so what was tested is what arrives?
Veyvora answers yes on every order, independent assay, a CoA on request against the batch number, and cold dispatch within 24 hours, paperwork packed inside.
pairs well with
view all
Overview
This page sets out what the GLOW 70 Skin Repair Pen contains, what batch documentation to request before ordering, and how to place a UK purchase with the right compliance checks in place.
The GLOW 70 Skin Repair Pen is a 70 mg research-peptide blend comprising GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg, supplied in a 3 mL, 300-click multi-dose pen format, sold strictly for in-vitro laboratory research use only (Veyvora product specification, 2026). Each click delivers approximately 233 µg of the combined blend. The pen is available from UK research suppliers; confirm current GBP pricing and stock directly with the operator before ordering.
| Specification | Detail |
|---|---|
| Blend name | GLOW 70 Skin Repair Pen |
| Total peptide content | 70 mg |
| Composition | GHK-Cu 50 mg · BPC-157 10 mg · TB-500 10 mg |
| Volume | 3 mL |
| Clicks per pen | 300 |
| Dose per click | ~233 µg (combined blend) |
| Intended use | Research use only, not for human or animal use |
The MHRA (Medicines and Healthcare products Regulatory Agency) determines medicine classification case by case and has stated that “research purposes” labelling does not override medicines law [2]. Verify batch documentation and a current Certificate of Analysis (CoA) before placing any laboratory order.
Product Identity and Scope
This listing covers a single product: the GLOW 70 Skin Repair Pen, a 70 mg research-peptide blend comprising GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg, supplied in a 3 mL, 300-click multi-dose pen format and sold strictly for in-vitro laboratory research use only (Veyvora product specification, 2026). Each click delivers approximately 233 µg of the combined blend, calculated as 70 mg divided across 300 clicks.
The MHRA has confirmed that “research purposes” labelling does not automatically place a product outside medicines law, meaning a supplier’s choice of label carries no regulatory weight on its own [2]. Prospective buyers should verify your GLOW 70 batch against its CoA before first use, and should understand what HPLC purity does and does not prove when evaluating analytical documentation.
Format descriptions vary across vendors; confirm the exact physical format (pre-filled pen, cartridge or lyophilised vial) with the operator before ordering. Current GBP pricing and UK stock status must be verified directly with the supplier at the point of purchase.
Verified Specifications
Composition and Format
| Parameter | Specified value | Source |
|---|---|---|
| Total peptide content | 70 mg | Veyvora product specification, 2026 |
| GHK-Cu | 50 mg | Veyvora product specification, 2026 |
| BPC-157 | 10 mg | Veyvora product specification, 2026 |
| TB-500 | 10 mg | Veyvora product specification, 2026 |
| Fill volume | 3 mL | Veyvora product specification, 2026 |
| Clicks per pen | 300 | Veyvora product specification, 2026 |
| Dose per click | ~233 µg (combined) | Calculated: 70 mg ÷ 300 |
| Physical format | Confirm with operator | — |
The physical format (pre-filled pen, lyophilised vial or cartridge) is not consistent across vendors, so confirm the exact format with the operator before ordering. Researchers evaluating BPC-157 and TB-500 in isolation can consult the BPC-157 versus TB-500 comparison page, which covers the relevant analytical distinctions without expanding this transactional listing into a general compound guide.
Batch Documentation and Analytical Evidence
Batch documentation for the GLOW 70 Skin Repair Pen is vendor-attested rather than independently verified: suppliers link each vial to a batch number, a CoA, and stated analytical methods, but the surfaced content does not expose the underlying purity values, chromatograms or test dates for any specific lot. Those details remain unconfirmed until the operator provides the full CoA on request.
What Supplier Documentation Typically Covers
Vendors in this category describe CoAs as recording UPLC/MS (ultra-performance liquid chromatography/mass spectrometry) purity results cross-referenced to the batch number printed on the vial, with testing attributed to named third-party laboratories. A CoA of this type confirms that a specific batch was submitted for analysis and that a result was recorded. It cannot, on its own, confirm that the result meets a defined purity threshold unless that threshold and the raw chromatogram are also disclosed.
Regulatory Context for Analytical Claims
The European Medicines Agency’s (EMA) guideline on synthetic peptides notes that peptides are often hygroscopic, meaning they readily absorb moisture from the air, and that storage and handling conditions directly affect measured purity, so a CoA result carries weight only when cold-chain and desiccation conditions between manufacture and testing are also documented [1]. Request the full CoA, the test date, and the storage conditions recorded at the time of analysis before accepting a batch for in-vitro use.
Researchers evaluating a broader skin-focused research stack can review the Skin Stack research pens page for related catalogue options. Buyers who find the GLOW 70 format does not meet their traceability requirements can consult Repair & Recovery Research Pens for alternative formats with comparable documentation.
Handling and Storage
Peptide materials in the GLOW 70 category require refrigerated storage at 2–8 °C, protected from moisture and light. These conditions align with the EMA’s synthetic-peptides guideline, which recommends refrigerated storage at 5 °C ± 3 °C or frozen conditions at −20 °C ± 5 °C to minimise degradation; where desiccation is a concern, the guideline notes that inert-atmosphere or desiccant storage may be appropriate [1].
Veyvora states that GLOW 70 orders are dispatched in insulated, gel-packed 2–8 °C mailers fitted with a temperature-indicator strip within 24 hours of order; operators must confirm current delivery availability for their specific market before placing an order (Veyvora shipping specification, 2026). Product-specific stability data, including confirmed shelf life after first use and in-use storage duration for the multi-dose pen format, are not independently verified from the sources available here and should be requested directly from the operator before first use.
To match the batch number printed on the pen against its public certificate, use the verify your GLOW 70 batch against its CoA tool. For a precise account of what an HPLC (high-performance liquid chromatography) purity figure does and does not confirm about identity or stability, see what HPLC purity does and does not prove.
Ordering Information
GLOW 70 Skin Repair Pen orders are fulfilled by Veyvora, which states same-day dispatch for orders placed before the daily cut-off, with delivery into the UK market via insulated cold-chain mailers (Veyvora ordering page, 2026). Pricing, current stock status and precise cut-off times are subject to live-page changes; confirm all figures directly with the operator before placing an order, as values may differ between the homepage listing and the product page.
What to Confirm Before Ordering
Contact the operator to verify the following before purchase:
- Current GBP price and any volume or distributor pricing tiers
- Live UK stock availability and estimated dispatch date
- Delivery cut-off time for next-day UK service and cold-chain mailer specification, including temperature-indicator strip inclusion
- CoA availability for the specific batch number assigned to your order
- Export or import restrictions applicable to your market
The MHRA assesses the medicine status of peptide products on a case-by-case basis and does not accept a “research purposes” label as a blanket exemption from medicines law, so procurement decisions should be grounded in batch documentation, CoA availability and storage compliance [2]. For prerequisite handling requirements that apply from the moment of receipt, see storage and stability guidance for research peptides. Researchers evaluating the BPC-157 and TB-500 components individually before committing to the blend can refer to the BPC-157 versus TB-500 comparison page.
Research-Use-Only Limitations
GLOW 70 Skin Repair Pen is supplied strictly as a research-use-only laboratory material, not for human or animal consumption, application, injection, ingestion, inhalation or administration, and the product is not classified as a medicine, medical device, food supplement, cosmetic or veterinary product under its supplier framing (Veyvora product disclaimer, 2026).
The MHRA determines medicine status on a case-by-case basis and may disregard “research purposes” claims where those claims appear to be used to avoid medicines regulation, meaning the research-use-only designation is a supply-context statement, not a regulatory clearance [2]. Buyers evaluating a broader in-vitro programme can review the Skin Stack research pens catalogue, or consult Repair & Recovery Research Pens for alternative formats where GLOW 70 does not meet the required specification.
Related Research and Comparison Pages
Two analytical questions sit between the CoA and first use: whether the batch number on the pen matches the public certificate, and what an HPLC purity figure actually confirms. To resolve the first, verify your GLOW 70 batch against its CoA before handling the material. To resolve the second, what HPLC purity does and does not prove sets out why a purity percentage is not a complete statement of identity or stability, a distinction that matters when selecting between suppliers whose CoAs differ in method or scope [1].
Comparison across vendors should focus on traceability criteria: batch ID format, named testing laboratory, assay method (HPLC, mass spectrometry, endotoxin), and whether the CoA is publicly accessible before purchase rather than available only on request after payment. Format consistency is not guaranteed across the market; some suppliers present GLOW 70 as a pre-filled pen and others as a lyophilised cartridge, so confirming the physical format against your laboratory protocol is a prerequisite, not an afterthought.
Confirm current stock and delivery availability for your location directly with the operator, cross-reference the batch number printed on the pen against the public CoA before first use, and then proceed to the operator checkout to place your order.
Key Takeaways
- The GLOW 70 Skin Repair Pen contains 70 mg total peptide across three compounds, GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg, in a 300-click, 3 mL pen delivering approximately 233 µg per click.
- Batch documentation is vendor-attested; request the full CoA, test date and storage conditions before accepting any lot for in-vitro use.
- The MHRA does not treat “research purposes” labelling as an automatic exemption from medicines law; treat the research-use-only designation as a supply-context statement only.
- Confirm GBP pricing, UK stock status, physical format and cold-chain specification directly with the operator before ordering.
Sources
[1] ema.europa.eu, https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-development-manufacture-synthetic-peptides_en.pdf [2] Borderline products: how to tell if your product is a medicine - GOV.UK (MHRA), gov.uk, https://www.gov.uk/guidance/borderline-products-how-to-tell-if-your-product-is-a-medicine
